T0	Disease 101 107	cancer
#1	AnnotatorNotes T0	DOID:162
T12	Disease 660 677	pancreatic cancer
#4	AnnotatorNotes T12	DOID:1793
T13	Disease 697 703	cancer
T14	Drug 757 766	SCH772984
T15	Disease 772 778	cancer
T2	Disease 201 205	PDAC
T21	Disease 940 951	desmoplasia
T22	Disease 973 977	PDAC
T23	Disease 1230 1234	PDAC
T6	Disease 396 400	PDAC
T8	Disease 509 515	cancer
T1	GeneFamily 74 77	RAS
#6	AnnotatorNotes T1	family:389
T3	GeneFamily 78 81	RAF
#11	AnnotatorNotes T3	family:1157
T4	GeneFamily 82 85	MEK
#13	AnnotatorNotes T4	not found
T5	GeneFamily 86 89	ERK
#14	AnnotatorNotes T5	not found
T7	Gene-Protein 126 132	ERK1/2
#15	AnnotatorNotes T7	HGNC:6877, HGNC:6871
T9	Gene-Protein 279 285	ERK1/2
T19	Gene-Protein 306 312	ERK1/2
T24	Gene-Protein 371 377	ERK1/2
T25	Gene-Protein 478 484	ERK1/2
T26	Gene-Protein 579 585	ERK1/2
T27	Gene-Protein 847 853	ERK1/2
T11	Drug-Class 743 756	ERK inhibitor
#2	AnnotatorNotes T2	DOID:3498
T10	Biomarker 124 143	p-ERK1/2 expression
T16	Biomarker 357 392	activation of ERK1/2 also increased
R1	Association Arg1:T10 Arg2:T2	
R2	Association Arg1:T16 Arg2:T6	
T28	Disease 539 543	PDAC
T29	Collection 509 543	cancerâ€“stromal interaction in PDAC
T30	Biomarker 464 484	activation of ERK1/2
T31	Biomarker 565 585	activation of ERK1/2
R3	Association Arg1:T30 Arg2:T29	
R4	Association Arg1:T31 Arg2:T12	
#3	AnnotatorNotes T14	C587178
#8	AnnotatorNotes T21	not found
T32	Disease 1072 1076	PDAC
T33	Drug-Class 1028 1046	anti-stromal drugs
R6	Response Arg1:T33 Arg2:T32	
T18	Drug 1154 1169	inhibiting PSCs
R7	Response Arg1:T18 Arg2:T23	
T20	Disease 639 643	PCCs
T34	Disease 873 877	PCCs
#9	AnnotatorNotes T20	DOID:1793
T35	Disease 237 243	HMPDAC
#10	AnnotatorNotes T35	DOID:3498
T36	Biomarker 254 285	high levels of activated ERK1/2
R8	Association Arg1:T36 Arg2:T35	
#7	AnnotatorNotes T18	not found
T37	Biomarker 879 901	Cancer-associated PSCs
R5	Association Arg1:T37 Arg2:T17	
T17	Collection 940 977	desmoplasia, which contribute to PDAC
